Cita APA

Fernando Arevalo, J. (2013). Intravitreal Bevacizumab as Anti-Vascular Endothelial Growth Factor in the Management of Complications of Proliferative Diabetic Retinopathy. Medical Hypothesis, Discovery & Innovation Ophthalmology.

Citación estilo Chicago

Fernando Arevalo, J. Intravitreal Bevacizumab As Anti-Vascular Endothelial Growth Factor in the Management of Complications of Proliferative Diabetic Retinopathy. Medical Hypothesis, Discovery & Innovation Ophthalmology, 2013.

Cita MLA

Fernando Arevalo, J. Intravitreal Bevacizumab As Anti-Vascular Endothelial Growth Factor in the Management of Complications of Proliferative Diabetic Retinopathy. Medical Hypothesis, Discovery & Innovation Ophthalmology, 2013.